These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 25748560

  • 1. Prevalence of HIV, HCV, and High-Risk Behaviors for Substance Users in Drop in Centers in Southern Iran.
    Salehi A, Naghshvarian M, Marzban M, Bagheri Lankarani K.
    J Addict Med; 2015; 9(3):181-7. PubMed ID: 25748560
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran.
    Hosseini M, SeyedAlinaghi S, Kheirandish P, Esmaeli Javid G, Shirzad H, Karami N, Jahani M, Seyed Ahmadian M, Payvarmehr F, Mohraz M, Emadi Koochak H, McFarland W.
    Arch Iran Med; 2010 Jul; 13(4):318-23. PubMed ID: 20597566
    [Abstract] [Full Text] [Related]

  • 3. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
    Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF.
    Clin Infect Dis; 2005 Jul 01; 41 Suppl 1():S18-24. PubMed ID: 16265609
    [Abstract] [Full Text] [Related]

  • 4. High prevalence of HCV coinfection in HIV-infected individuals in Shiraz, Islamic Republic of Iran.
    Alipour A, Rezaianzadeh A, Hasanzadeh J, Rajaeefard A, Davarpanah MA, Hasanabadi M.
    East Mediterr Health J; 2013 Dec 01; 19(12):975-81. PubMed ID: 24684094
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis C infection among drug users in northern Thailand.
    Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano D, Razak MH, Srirak N, Vongchak T, Kawichai S, Thomas D, Sripaipan T, Netski D, Ananthakrishnan A, Nelson KE.
    Am J Trop Med Hyg; 2006 Jun 01; 74(6):1111-6. PubMed ID: 16760529
    [Abstract] [Full Text] [Related]

  • 6. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B, Narayanan S, Navaratnam V.
    Drug Alcohol Rev; 2009 Jul 01; 28(4):447-54. PubMed ID: 19594801
    [Abstract] [Full Text] [Related]

  • 7. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D, Wejnert C, Pham HT, DiNenno E, Heffelfinger JD, Cribbin M, Krishna N, Teshale EH, Paz-Bailey G, National HIV Behavioral Surveillance System Study Group.
    MMWR Surveill Summ; 2014 Jul 04; 63(6):1-51. PubMed ID: 24990587
    [Abstract] [Full Text] [Related]

  • 8. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
    Imani R, Karimi A, Rouzbahani R, Rouzbahani A.
    East Mediterr Health J; 2008 Jul 04; 14(5):1136-41. PubMed ID: 19161086
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.
    Leprêtre A, Ba I, Lacombe K, Maynart M, Toufik A, Ndiaye O, Kane CT, Gozlan J, Tine J, Ndoye I, Raguin G, Girard PM.
    J Int AIDS Soc; 2015 Jul 04; 18(1):19888. PubMed ID: 26004637
    [Abstract] [Full Text] [Related]

  • 10. Risk Factors and predictors of human immunodeficiency virus infection among injection drug users.
    Backmund M, Meyer K, Henkel C, Reimer J, Wächtler M, Schütz CG.
    Eur Addict Res; 2005 Jul 04; 11(3):138-44. PubMed ID: 15990431
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
    Shirin T, Ahmed T, Iqbal A, Islam M, Islam MN.
    J Health Popul Nutr; 2000 Dec 04; 18(3):145-50. PubMed ID: 11262767
    [Abstract] [Full Text] [Related]

  • 12. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY, Lin HH, Liu YC, Lee SS, Chen YL, Hung CC, Ko WC, Huang CK, Lai CH, Chen YS, Shih YL, Chung HC, Liang SH, Lin JN.
    Clin Infect Dis; 2008 Jun 01; 46(11):1761-8. PubMed ID: 18433337
    [Abstract] [Full Text] [Related]

  • 13. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S, Panda S, Sarkar K, Hangzo CZ, Bijaya L, Singh NY, Das N, Agarwal A, Chatterjee A, Deb BC.
    Indian J Public Health; 1995 Jun 01; 39(3):86-92. PubMed ID: 8690497
    [Abstract] [Full Text] [Related]

  • 14. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
    Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS.
    PLoS One; 2008 Jun 01; 3(10):e3608. PubMed ID: 18974888
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J.
    Arch Virol; 2013 Sep 01; 158(9):1889-94. PubMed ID: 23553454
    [Abstract] [Full Text] [Related]

  • 16. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M.
    Int J Infect Dis; 2010 Jan 01; 14(1):e28-33. PubMed ID: 19464218
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.
    Zamani S, Radfar R, Nematollahi P, Fadaie R, Meshkati M, Mortazavi S, Sedaghat A, Ono-Kihara M, Kihara M.
    Int J Drug Policy; 2010 Nov 01; 21(6):493-500. PubMed ID: 20483578
    [Abstract] [Full Text] [Related]

  • 18. [Prevalence of hepatitis B, hepatitis C and HIV among injecting drug users treated outpatiently and in therapeutic community in Brod-Posavina County, Croatia].
    Kolovrat A, Jurisić I, Marić Z, Cvitković A.
    Acta Med Croatica; 2010 Oct 01; 64(4):287-96. PubMed ID: 21688612
    [Abstract] [Full Text] [Related]

  • 19. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
    Zhao R, Peng J, Tang L, Huang H, Liu M, Kong W, Pang B.
    J Med Virol; 2013 Oct 01; 85(10):1712-23. PubMed ID: 23868809
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.
    Min JA, Yoon Y, Lee HJ, Choi J, Kwon M, Kim K, Lee CU, Kim DJ, Yun H.
    J Med Virol; 2013 Apr 01; 85(4):575-82. PubMed ID: 23364858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.